UBC Medical Indonesia Tbk. vs Ristia Bintang Mahkotasejati Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume), while Ristia Bintang Mahkotasejati Tbk. trades at Rp69 (market cap 154.06B, 373.84M 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 3.7× Ristia Bintang Mahkotasejati Tbk.'s market cap, and Ristia Bintang Mahkotasejati Tbk. is more actively traded (373.84M versus 3.48M). Which is the better fit depends on your goals.
| LABS | RBMS | |
|---|---|---|
Market Cap | 576.7B | 154.06B |
Volume | 3.48M | 373.84M |
Lot | 34.82K | 3.74M |
Turnover | 522.79M | 24.62B |
Average Price | 150.13 | 65.86 |
Value | 522.79M | 24.62B |
Indicative Equilibrium Price | 148 | 69 |
Indicative Equilibrium Volume | 350 | 173.84K |
Trailing returns across standard periods
Latest headlines on both assets
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →PT Ristia Bintang Mahkotasejati Tbk (the Company) was established based on the Notarial Deed No. 114 of Lieke Lianadevi Tukgali, S.H., dated May 22, 1985. PT. Ristia Bintang Mahkotasejati is a Real Estate developer and contractor. A company developing houses, store houses and also facilities supported in Bekasi, Tanggerang and Karawang.
Read more on RBMS →